Acasti Pharma Inc (ACST)

Finanzdaten der Acasti Pharma Inc-Aktie (ACST)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Research and Development	213.70% 1.443	0.46	1.095	1.64	2.45
Operating Income/Loss	45.46% -3.043	-2.092	-4.454	-38.07	-4.245
Nonoperating Income/Loss	127.29% 0.444	-1.627	0.142	0.115	0.082
Income/Loss From Continuing Operations Before Tax	30.12% -2.599	-3.719	-4.312	-37.96	-4.163
Income Tax Expense/Benefit	53.36% -0.208	-0.446	-0.289	-8.871	-0.274
Income/Loss From Continuing Operations After Tax	26.95% -2.391	-3.273	-4.023	-29.09	-3.889
Net Income/Loss	26.95% -2.391	-3.273	-4.023	-29.09	-3.889
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	52.35% 11.51	7.5527	7.4355	0.1149	44.61
Diluted Average Shares	52.35% 11.51	7.5527	7.4355	0.1149	44.61
Basic Earnings Per Share	51.16% -0.21	-0.43	-0.54	-0.65	-0.09
Diluted Earnings Per Share	51.16% -0.21	-0.43	-0.54	-0.65	-0.09
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-